Factors affecting the utilization of pap smear screening program among nurses in the department of medicine, Siriraj Hospital.

Objective: To determine factors affecting the utilization of Pap smear screening program among nurses in the Department of Medicine, Siriraj Hospital. The surveyed factors included knowledge of cervical cancer, attitude toward Pap smear screening, and the negative attitude toward Pap smear procedures. Methods: This study was a cross-sectional survey. A questionnaire was distributed to 400 nurses in the Department of Medicine. Results: The response rate was 98.3% (393/400). 113 nurses were eligible to have Pap smear (aged > 35 years). Only 34.5% of them had regular Pap smear screening. Knowledge and attitudes between regular and non-regular groups were not different (p-value = 0.90 and 0.97, respectively). Most of nurses had good attitude toward Pap smear. In non-regular Pap smear group, most of nurses refused to have Pap smear screening due to the perception of Pap smear procedures. Conclusion: There were no relationship between knowledge or attitude and the decision to utilize Pap smear screening program. Approximately 50% of nurses had good knowledge of cervical cancer. Most of the nurses had good attitudes toward Pap smear regardless of the utilization of Pap smear screening. However, the nurses who did not use the screening program tended to have negative attitude toward Pap smear procedures.

Chrono impact versus enteric coated valproate in Thai epileptic patients.

BACKGROUND: Since its first clinical use more than 30 years ago, Valproic acid is still being widely prescribed It has been available in Thailand for more than 20 years. Sodium valproate slow-released (SVSR) form has been used in clinical practice in Thailand since 1990. The objectives of this open study were to access the compliance and satisfaction consequences in the epileptic patients. MATERIAL AND METHOD: In this prospective, multi-center study, the authors compared the compliance and satisfaction consequences in epileptic patients switched from more than two times daily sodium valproate enteric-coated tablet (SVEC) regimen to the same total daily dose of SVSR form given once or twice daily. RESULTS: Eighty-nine of the 100 patients completed the study. 43.8% were male (39 of 89 patients). Mean age was 34.74 +/- 12.67 years. Most common etiology of epilepsy was idiopathic 40.4%. Patients were very/fairly happy with the SVSR form 94.4% compared to the SVEC form 56.2% (p = 0.000). Patients had been experiencing no problem with the SVSR form 67.4% compared to SVEC form 38.2% (p = 0.000) and also never missing taking SVSR. form 77.5% compared to SVEC form 40.4% (p = 0.000). According to convenience, patients preferred to administer SVSR form once a day 92.1% and never over taking dosed the antiepileptic drug 96.6%. SVSR form had fewer side effects than the enteric-coated form interms of memory problem (40.4% vs 48.3%) (p = 0.000), sleepiness (30.3% vs 42.7%) (p = 0.041) and difficulty in thinking clearly (38.2% vs 44.9%) (p = 0.001). The patients were seizure free during the study period comparing SVSR form 76.4% to SVEC form 65.2% (p = 0.011). CONCLUSION: Patients preferred once daily regime. Switching from SVEC to SVSR form increased seizure free, reduced side effects, improved patient's compliance and satisfaction.

Neurocysticercosis : Clinical manifestations and assessments.

Objective : In patients who have symptoms of epilepsy and other neurological deficits, one of the most common parasitic infections is neurocysticercosis (NCC) caused by Cysticercus cellulosae, the larval form of Taenia solium. In order to evaluate the characteristics of this illness which define the diagnosis, we assessed clinical manifestations, a positive ELISA for cysticercosis and neurological imaging in patients suspected of having NCC at a teaching hospital. Methods : This retrospective cohort study assessed 44 patients, who had laboratory results and clinical manifestations compatible with a diagnosis of NCC, between November 1998 and November 2001. The criteria for diagnosing this illness modified from these of Del Brutto and colleagues\\\' criteria. All patients were investigated with serum ELISA, 18 with CSF ELISA, if there was no contraindication. T. solium vesicular cyst soluble antigen was used for the detection of cysticercosis (T. solium) antibodies by solid-phase enzyme immunoassay. 35 patients were further investigated by a computerized tomography (CT) scan of central nervous system (CNS), if the results of other investigations were inconclusive. Using these criteria, we stratified all patients into three groups: possible NCC (19), probable NCC (10), and definite NCC (15). All definite patients were further examined with ELISA for Angiostrongylus cantonensis and Western blot for Gnathostoma spinigerum in order to look for cross-reactivity of the ELISA for cysticercosis. Results : In this study, a prevalence of NCC (34.1%) in the group of patients in whom there was clinical suspicion of NCC makes us concerned that Thailand is still an endemic area for this disease. The three most common clinical presentations were seizures, neurological deficit, and signs of increased intracranial pressure. Serum ELISA showed a sensitivity of 33.3% and a specificity of 93.1%. CSF ELISA showed a sensitivity of 40.0% and a specificity of 100%. CT scan brain showed a high sensitivity (92.9%) with a modest specificity (52.4%). Cross-reaction with other parasitic proteins was found with A. cantonensis (6.7%), but not with G. spinigerum. Conclusion : NCC is still endemic in Thailand. In the approach to this illness, we conclud that the diagnosis of NCC should be based on the patient's history and physical signs in conbination with radiological and serological investigations. Moreover, in areas where A. cantonensis and G. spinigerum were also prevalent, case should be taken in the interpretation of a positive ELISA for cystercercosis because of cross-reactivity with antibodies to A. cantonensis which should be checked individually.

Cerebral toxoplasmosis in AIDS patients: Clinical manifestations and laboratory diagnosis.

Objective : Patients with acquired immunodeficiency syndrome (AIDS) are susceptible to a variety of infections. Cerebral toxoplasmosis is one of the most common. The presumptive diagnosis is based on clinical manifestations, a positive Toxoplasma antibody test, characteristic neuroradiological abnormalities, and improvement after specific therapy. We evaluated not only the clinical manifestations and laboratory diagnosis but also its prevalence and the CD4 count in relationship to the development of cerebral toxoplasmosis in order to determine its place in the natural history of HIV infection. Methods : A retrospective cohort study was performed in 104 AIDS patients who were stratified into three levels: 35 with a definite diagnosis of cerebral toxoplasmosis and 41 with a probable diagnosis and 104 with a possible diagnosis. The criterion for diagnosing definite illness was a good response to specific treatment. Toxoplasma IgM were detected using solid-phase enzyme immunoassay and monoclonal captured ELISA methods respectively in all patients. 65 cases without a definitive diagnosis were further investigated with a CT scan of the brain. The patient data were followed up on day 7 and 14. Result : Toxoplasma IgG was present in 37 out of all case (35.6%) and Toxoplasma IgM was positive in only one case. The study showed that ELISA was a valuable method for diagnosis in addition of a CT scan of the brain. The ELISA detected antibodies in 24 out of 35 cases with a definite diagnosis (sensitivity 68.6%, 95% CI 5.7%-83.2%) and no antibody in 56 out of 69 cases with other diagnoses (specificty 81.2%, 95% CI 69.9%-89.6%). The CT scan showed positive features in 30 out of 33 cases with definite diagnosis (sensitivity 90.9%, 95% CI 75.7%-98.1%) but there were 4 (out of 32 cases) with a positive CT scan who were negative for the diagnosis, i.e., false positive, giving a specificity of 87.5%, 95% CI 71.0%-96.5%. The most common clinical presentations were headache and neurological deficit. Interestingly, neurological deficit was the only clinical manifestation that was associated with cerebral toxoplasmosis, when the group with a definite diagnosis was compared with the other diagnosis group (p-value 0.006). In HIV seropositive patients with previous Toxoplasma infection, cerebral toxoplasmosis was present in 24 out of 37 cases who were positive for Toxoplasma IgG (positive predictive value 64.9%), particularly in individuals with a CD4 count less than 100 cells/mm1. Conclusion : The two most common clinical manifestations were headache and neurological deficit. Detection of Toxoplasma gondii IgG and CT scan of the brain are valuable tools for the diagnosis of cerebral toxoplasmosis. Cerebral toxoplasmosis is mainly caused by reactivation, as Toxoplasma IgM antibodies were found in only one case.